{"id":9419,"date":"2025-05-11T01:23:36","date_gmt":"2025-05-11T05:23:36","guid":{"rendered":"https:\/\/sharewatch.com\/wp\/2025\/05\/11\/elizabeth-holmess-partner-has-a-new-blood-testing-start-up\/"},"modified":"2025-05-11T01:23:36","modified_gmt":"2025-05-11T05:23:36","slug":"elizabeth-holmess-partner-has-a-new-blood-testing-start-up","status":"publish","type":"post","link":"https:\/\/sharewatch.com\/wp\/2025\/05\/11\/elizabeth-holmess-partner-has-a-new-blood-testing-start-up\/","title":{"rendered":"Elizabeth Holmes\u2019s Partner Has a New Blood-Testing Start-Up"},"content":{"rendered":"
\n
\n

Elizabeth Holmes is in prison for defrauding investors through her blood-testing company, Theranos. In the meantime, her partner is starting one of his own.<\/p>\n

Billy Evans, who has two children with Ms. Holmes, is trying to raise money for a company that describes itself as \u201cthe future of diagnostics\u201d and \u201ca radically new approach to health testing,\u201d according to marketing materials reviewed by The New York Times.<\/p>\n

If that sounds familiar, it\u2019s because Theranos similarly aimed to revolutionize diagnostic testing. The Silicon Valley start-up captured the world\u2019s attention by claiming, falsely as it turned out, to have developed a blood-testing device that could run a slew of complex lab tests from a mere finger prick.<\/p>\n<\/div>\n<\/aside>\n<\/div>\n

\n
\n

Mr. Evans\u2019s company is named Haemanthus, which is a flower also known as the blood lily. It plans to begin with testing pets for diseases before progressing to humans, according to two investors pitched on the company who spoke on the condition of anonymity because they had agreed to keep the plans secret. Mr. Evans\u2019s marketing materials, which lay out hopes to eventually raise more than $50 million, say the ultimate goal is nothing short of \u201chuman health optimization.\u201d<\/p>\n

\n
\n
Image<\/span><\/p>\n
\n
<\/div>\n<\/div>\n<\/div>
The Haemanthus testing device.<\/span>Credit…<\/span>Haemanthus<\/span><\/span><\/span><\/figcaption><\/figure>\n<\/div>\n

A photo provided to potential investors of the start-up\u2019s prototype bears more than a passing physical resemblance to Theranos\u2019s infamous blood-testing machine, variously known as the Edison or miniLab. The device that Mr. Evans\u2019s company is developing is a rectangular contraption with a door, a digital display screen and what the investor materials describe as tunable lasers inside.<\/p>\n

\n
\n
<\/div>\n